© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
The new astaxanthin derived from yeast fermentation called Astaferm is specifically designed for softgel applications and will be offered as ready-to-use softgels.
NextFerm (Yokneam, Israel) and Soft Gel Technologies (Commerce, CA) are releasing a new astaxanthin derived from yeast fermentation called Astaferm. The ingredient is specifically designed for softgel applications and will be offered as ready-to-use softgels, with plans to release a special grade for gummies in the future.
“We’re very excited about the way the market is responding to our new approach and messaging, and the backing of a reputable contract manufacturer in Soft Gel means a lot to us,” said Elzaphan Hotam, CEO of NextFerm USA, in a press release. “The addition of a softgel application to our previous launch of gummies adds yet another important segment to our marketing efforts and our reach.”
“For us, we see a great opportunity to introduce a new and fresh approach to what was a completely generic and stagnant market until recently. Astaferm is a non-GMO, sustainable, and non-marine-sourced astaxanthin,” said Steve Holtby, president and CEO of Soft Gel Technologies, Inc., in a press release. “This is a natural and effective product, which offers brands a simple way to differentiate themselves at a competitive price and without compromising on the highest quality standards.”